SCHEMBL20176740

SCHEMBL20176740

c1ccc(-c2c3ccccc3c(-c3ccc(-c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)nc3)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.43
PLA2G4A P47712 4/20 0.43
NPC1 O15118 2/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PLA2G10 O15496 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
HPGDS O60760 1/20 0.37
LMNA P02545 1/20 0.36
CDK1 P06493 2/20 0.36
CCNB1 P14635 2/20 0.36
CCNE1 P24864 2/20 0.36
CDK2 P24941 2/20 0.36
CCNE2 O96020 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26161078 1.00 PLA2G2A (0.43) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26161076 0.96 PLA2G2A (0.41) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL20176739 0.95 NPC1 (0.41) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26160989 0.93 PLA2G2A (0.44) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26161161 0.93 PLA2G2A (0.44) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26161163 0.93 PLA2G2A (0.44) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26160987 0.92 PLA2G2A (0.42) PLA2G2APLA2G4ANPC1MAPTKDM4E
SCHEMBL26161097 0.90 ESR1 (0.39) PLA2G2APLA2G4AKMT2APLA2G10HDAC6
SCHEMBL20176793 0.90 ESR1 (0.39) PLA2G2APLA2G4AKMT2APLA2G10HDAC6
SCHEMBL26161075 0.88 AHR (0.40) PLA2G2APLA2G4ANPC1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 PLA2G2A 3903/4885PLA2G4A 4077/4885NPC1 1168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.